Targeting 7-Dehydrocholesterol Reductase Integrates Cholesterol Metabolism and IRF3 Activation to Eliminate Infection.

Journal: Immunity

Published: 2019-12-20

DOI: 10.1016/j.immuni.2019.11.015

Affiliations: 17

Authors: 22

Go to article
Institutions Share
CAS Center for Excellence in Molecular Cell Science, SIBS CAS, China 0.17
State Key Laboratory of Cell Biology (SKLCB), IBCB SIBS CAS, China 0.14
CAS Key Laboratory of Systems Biology, SIBS CAS, China 0.14
University of Chinese Academy of Sciences (UCAS), Shanghai, China 0.14
State Key Laboratory of Veterinary Biotechnology, HVRI CAAS, China 0.09
State Key Laboratory of Virology (SKLV), China 0.06
School of Life Sciences, SHU, China 0.06
Huashan Hospital, Fudan University, China 0.05
CAS Key Laboratory of Nutrition and Metabolism, SIBS CAS, China 0.03
Shanghai Institute of Nutrition and Health, CAS, China 0.03
Cancer Center at Shanghai Tenth People's Hospital, Tongji University, China 0.02
State Key Laboratory of Pharmaceutical Biotechnology, NJU, China 0.02
MOE Key Laboratory of Model Animal for Disease Study, NJU, China 0.02
Nanjing Biomedical Research Institute (NBRI), NJU, China 0.02
Harvard Department of Immunology, United States of America (USA) 0.01
NIH NCI Experimental Immunology Branch, United States of America (USA) 0.01

Return

Except where otherwise noted © 2020 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER